# A Clinical Study to Evaluate the Safety and Efficacy of Aliskiren Alone and in Combination With Ramipril in Hypertensive, Diabetic Patients.

> **NCT00219089** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 839 (actual)

## Conditions studied

- Hypertension, Diabetes Mellitus

## Interventions

- **DRUG:** aliskiren

## Key facts

- **NCT ID:** NCT00219089
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2005-08
- **Final completion:** 2005-08
- **Target enrollment:** 839 (ACTUAL)
- **Last updated:** 2017-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00219089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00219089, "A Clinical Study to Evaluate the Safety and Efficacy of Aliskiren Alone and in Combination With Ramipril in Hypertensive, Diabetic Patients.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00219089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*